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Abstract
Introduction: Adult mesenchymal stem cells (MSCs) are considered promising candidates for cell-based therapies.
Their potential utility derives primarily from their immunomodulatory activity, multi-lineage differentiation potential,
and likely progenitor cell function in wound healing and repair of connective tissues. However, in vitro, MSCs often
senesce and spontaneously differentiate into osteoblasts after prolonged expansion, likely because of lack of
regulatory microenvironmental signals. In vivo, osteoblasts that line the endosteal bone marrow surface are in close
proximity to MSCs in the marrow stroma and thus may help to regulate MSC fate.
Methods: We examined here how osteogenic differentiation of MSCs in vitro is affected by exposure to
osteoblastic cells (OBCs). Human bone marrow MSCs were exposed to OBCs, derived by induced osteogenic
differentiation of MSCs, either directly in contact co-cultures, or indirectly to OBC-conditioned medium or
decellularized OBC extracellular matrix (ECM).
Results: Our results showed that OBCs can act as negative regulators of MSC osteogenesis. mRNA expression
profiling revealed that OBCs did not affect MSC osteogenesis in direct contact cultures or via secreted factors.
However, seeding MSCs on decellularized OBC ECM significantly decreased expression of several osteogenic genes
and maintained their fibroblastic morphologies. Proteomic analysis identified some of the candidate protein
regulators of MSC osteogenesis.
Conclusions: These findings provide the basis for future studies to elucidate the signaling mechanisms responsible
for osteoblast matrix-mediated regulation of MSC osteogenesis and to better manipulate MSC fate in vitro to
minimize their spontaneous differentiation.
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Introduction
Mesenchymal stem cells (MSCs) are multipotent cells
resident in adult tissues that function in wound healing
and repair of connective tissues, especially the musculo-
skeletal system. Capable of extensive expansion in vitro
[1], they are an exciting cell type to study because of
their therapeutic potential in tissue engineering and
regenerative medicine [2]. MSCs are commonly differenti-
ated into osteoblasts, chondrocytes and adipocytes [3], as
well as other cell types [4, 5]. Still more promising, MSCs
have been shown to have immunomodulatory properties,
allowing them to evade the immune system when trans-
planted [6].
A practical hurdle in the application of MSCs is their
tendency to undergo spontaneous differentiation upon
extended propagation in vitro. Specifically, osteogenesis
appears to be the default differentiation pathway for long
term cultures of MSCs [7], causing them to senesce and
lose their therapeutic potential. However, in vivo, both
of these processes are prevented due to the specialized
niche in which MSCs reside. Recapitulation of this niche
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in vitro would permit more extensive expansion of MSCs
without the loss of their multi-lineage differentiation po-
tential. The feasibility of such an endeavor requires under-
standing the nature of the MSC niche.
In the bone marrow, the MSC niche is, at least par-
tially, perivascular [8]. However, MSCs are likely in con-
tact with both endothelial cells and osteoblasts (OBs),
which line the bone marrow cavity. Since OBs have been
implicated in the hematopoietic stem cell niche [9, 10],
it seems likely that they could also be key players in the
MSC niche. A number of studies have assessed the ef-
fects of OBs and their secreted soluble and extracellular
matrix (ECM) proteins on MSC osteogenesis [11–15].
For example, co-culturing of embryonic mouse MSCs
and OBs, separated in a Transwell set-up, showed that
factors secreted by OBs can cause a 30-fold increase in
MSC proliferation and a decrease in their alkaline phos-
phatase (ALP) activity, indicative of less osteogenic dif-
ferentiation [11]. While the active factors responsible for
this observed effect have not been ascertained, both
bone morphogenetic proteins (BMPs) and insulin-like
growth factors (IGFs) are secreted by OBs and have been
implicated in several niche functions in other systems,
including stem cell maintenance [16-18] and asymmetric
cell division [19].
On the other hand, both BMPs and IGFs can also be
found sequestered in the ECM of OBs; in fact, BMPs
were first identified in demineralized bone matrix
(DBM) because of their activity in inducing bone forma-
tion [20]. While several ECM molecules, in their purified
forms, have been shown to enhance bone formation
(e.g., collagen type I [21]), the reactivity of MSCs to na-
tive OB matrix, with its three-dimensionality and
protein-protein interactions, is likely to be more com-
plex. In addition, it is important to examine the interac-
tions between human MSCs and nascent human OBs,
the most likely osteoblastic cell type to interact with
MSCs in the native bone marrow environment. Mature
bone cells, such as fully differentiated OBs and osteo-
cytes, from which DBM is created, are encased in bony
matrix and are most likely exposed to MSCs only upon
tissue injury, such as bone fracture. This information
serves as the foundation for our study of MSC osteogen-
esis, in which we tested the effects of relatively immature
osteoblastic cells (OBCs), derived in vitro from MSCs.
Specifically, we have examined the influence of cell-cell
interaction, and secreted factors and extracellular matrix
produced by the OBCs on MSC osteogenic differentiation.
Materials and methods
Cell culture
Human femoral heads were generously obtained from Dr.
Paul Manner (University of Washington, Seattle) from
total hip arthroplasty patients with informed consent and
Institutional Review Board approval. Bone marrow MSCs
were isolated as described previously [16], plated in
expansion medium (EM) (DMEM, 9 % lot-selected fetal
bovine serum (Invitrogen, Grand Island, NY; MSC-
qualified), 1 % penicillin/streptomycin/Fungizone) in
150-cm2 culture flasks (Corning or Nunc), and incu-
bated at 37 °C, 5 % CO2. One to two days later,
hematopoietic cells were rinsed away with phosphate-
buffered saline (PBS) or Hank’s Balanced Salt Solution
(HBSS). MSCs were routinely passaged every three to
four days before reaching confluency.
To obtain OBCs, second or third passage MSCs were
trypsinized and re-plated in osteogenic medium (OM)
consisting of EM plus 10 mM β-glycerophosphate, 19.5
mM L-ascorbic acid-2-phosphate, 10 nM dexametha-
sone (all from Sigma-Aldrich, St. Louis, MO, USA), 10
nM 1,25-dihydroxyvitamin D3 (Enzo, Farmingdale, NY,
USA) [16]. MSCs were cultured in OM for a minimum
of 14 days before being considered OBCs.
Direct co-cultures of MSCs and OBCs
To assess endogenous levels of osteoblastic mRNAs in
osteogenically differentiating MSCs in contact with
OBCs, MSCs and OBCs were co-cultured in a 1:4 ratio
at 9,000-10,000 cells/cm2. Before co-culture, trypsinized
MSCs were stained with the cell tracker CM-DiI
(Thermo Fisher, Waltham, MA; 106 cells/mL + 8 μL CM-
DiI, 37 °C, for five min, then 4 °C, for 15 min) to distin-
guish them from OBCs and to allow subsequent
fluorescence-activated cell sorting (FACS). Three co-
culture combinations were tested in both EM and OM:
(1) DiI-labeled MSCs mixed with unlabeled OBCs, (2)
DiI-labeled MSCs mixed with unlabeled MSCs, and (3)
unlabeled, MSC-only cell populations, with the latter two
conditions serving as controls. Samples were harvested
pre-culture, and at culture days 6 and 12. MSC-only cul-
tures were trypsinized, centrifuged, resuspended in 1 mL
Trizol (Invitrogen), and stored at -80 °C; mixed cultures
were trypsinized and frozen in dimethyl sulfoxide
(DMSO) freeze medium (BioVeris Corporation, Gaithers-
burg, MD, USA) until the time course was complete. The
DiI-positive cells were fractionated using a Becton-
Dickinson three-laser Dako MoFlo FACS sorter, pelleted
by centrifugation, resuspended in 1 mL Trizol, and stored
at -80 °C. Osteogenesis was assessed by conventional real
time RT-PCR and by PCR array analysis (SuperArray,
Qiagen, Valencia, CA, USA; see below).
Conditioned medium cultures
To assess the effects of OB-secreted factors on MSC
osteogenesis, EM and OM were conditioned for three
days by OBCs that had completed 11-14 days of osteo-
genesis. Conditioned medium (CM) was frozen at -80 °C
until use. OM incubated without cells for three days,
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referred to as aged osteogenic medium (AOM), served
as the control. Thawed CM was mixed 1:1 with fresh
OM before use (Note: Fresh OM was added to minimize
possible medium nutrient deprivation as a confounding
factor). MSCs, seeded at 8-10 × 103 /cm2 in 6- and 12-
well plates and exposed to CM every three days, were
analyzed for osteogenesis, as described below.
Matrix cultures
The effects of devitalized/decellularized OBC ECM on
MSC osteogenesis were analyzed as follows: MSCs
seeded at a density of 8-10 × 103 cells/cm2 in 6-well
plates were cultured in OM for at least 14 days, rinsed
with HBSS, and decellularized by lysis, either with three
washes of 3 mL/well MilliQ-purified water (ddH2O) or
by one wash of 1 mL/well 0.5 % deoxycholate (Sigma-
Aldrich) in ddH2O (DOC) for 30 min at 4 °C. The plates
were then washed with HBSS three times for at least
three min each time. Live/Dead staining (Invitrogen)
was performed in one well of each treatment type to en-
sure 100 % cell death. MSCs were then seeded at 8-10 ×
103 cells/cm2 on top of the two types of matrix, with tis-
sue culture plastic as the control, and osteogenesis was
assessed as described below.
MSC proliferation was assessed fluorimetrically
(494 nm/567 nm), based on calcein incorporation
and Ca2+-dependent fluorescence, after Live/Dead staining
(Invitrogen) performed on a Wallac Victor2 V plate reader
(Perkin Elmer, Waltham, MA, USA). Nine measurements
were made in a 3 × 3 pattern within each well of a 24-well
plate, corrected with readings of matrix without cells.
Real-Time RT-PCR
RNA extracted from frozen Trizol samples was reverse
transcribed using oligo-d(T) and a First Strand Synthesis
kit (SSII, Invitrogen) and the cDNA was amplified using
SybrGreen (BioRad, Hercules, CA, USA) on an iCycler
(BioRad). Primer sets (5′–3′) were designed (see Add-
itional file 1: Table S1) for the following human genes:
osteocalcin (OC), ALP, Runx2, collagen type I, α2
(Col I), and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). Standard curves generated using a 10-fold dilu-
tion series created from a single batch of cDNA from day
18 OBCs derived from a single donor allowed relative
comparisons of mRNA copy numbers between donors
and experiments. Expression levels were normalized to
GAPDH in triplicate.
Microarray analysis
Human osteogenesis RT2 Profiler™ PCR Superarrays
(SABiosciences; http://www.sabiosciences.com/PCRAr-
rayPlate.php) were used to monitor 84 different genes
associated with osteogenesis. For the matrix study, 500
ng of cDNA were loaded per plate (5 ng/well). Since
FACS sorting yielded limited cell numbers in the co-
culture experiments, these samples were pre-amplified by
12 rounds of PCR prior to loading them on the Superarray
plates. A total of 17.5 ng of mRNA was pre-amplified
using RT2 Nano PreAMP cDNA synthesis kits plus the cor-
responding NanoAmp osteogenic primers (SABiosciences)
according to the manufacturer’s protocol.
The fluorescence threshold for each plate was adjusted
to give an average positive PCR control (PPC) value of
20 ± 2 cycle thresholds (CTs). Transcripts whose CTs
were >35 were assumed to be absent [22]. For pre-
amplified samples, the cut-off CT was 30, as recom-
mended by the manufacturer (personal communication,
SABiosciences representative).
Data analysis was carried out via the SABiosciences
web portal. The geometric mean of the housekeeping
gene CT values was subtracted from the CT value of
each gene of interest for normalization. Housekeeping
genes whose CT values varied by more than two-fold
among the conditions were excluded.
Osteogenic differentiation assays
To visualize matrix mineralization, cultures were stained
with 2 % Alizarin Red S (AlzR), pH 4.2 (Rowley Bio-
chemical Institute, Danvers, MA, USA). ALP activity
was monitored histochemically using the Fast Blue,
leukocyte alkaline phosphatase kit (Sigma, 86R-1KT).
Imaging
Histochemical staining was imaged at low (5X) and high
(63X) magnifications, and as whole-plate scans at a
resolution of 2,400 ppi. Fluorescent Live/Dead staining
was examined at 10× magnification and images analyzed
using AxioVision software.
2D-Differential in-gel electrophoresis (2D-DIGE) and
protein identification
Sample preparation
OBCs were cultured from three different MSC donors
and lysed as described for the matrix cultures. After the
final rinse, matrix proteins were extracted using 7 M
urea, 2 M thiourea, 30 mM Tris-HCl, 4 % CHAPS, pH
8.8 and stored at -80 °C until use. Proteins were precipi-
tated using the 2D Clean Up Kit (GE Healthcare Bio-
Sciences, Pittsburgh, PA, USA) and quantified by the 2D
Quant Kit (GE), with pH adjusted to 8.0 - 9.0. A stand-
ard was created by mixing together equivalent aliquots
of each sample.
CyDye labeling
Solutions of CyDyes 2, 3, and 5 (GE) in dimethylforma-
mide (Sigma) were added to the samples at final concen-
trations of 400 pmol per 50 μg protein. The standard
was labeled with Cy2 while individual samples were labeled
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with either Cy3 or Cy5, assigned randomly, for 30 min on
ice in the dark, followed by quenching with lysine (Sigma).
Samples were flash frozen and stored at -80 °C until use.
First dimension gel rehydration and sample loading
Thawed samples were equilibrated (1:1, v/v) with 2×
sample buffer (7 M urea, 2 M thiourea, 4 % CHAPS, 4 %
IPG 3-10, 6.2 mg diothiothreitol/mL) and pooled appro-
priately. Each mixture was added to rehydration buffer
(7 M urea, 2 M thiourea, 4 % CHAPS, 2 % IPG 3-10,
plus 12 μL DeStreak Solution [GE]/mL before use) for a
total volume of 340 μL, and used to rehydrate an Immo-
biline™ 18 cm IEF DryStrip, pH 3-10 (GE) overnight.
Isoelectric focusing
A Multiphor II electrophoresis unit (GE Healthcare Bio-
Sciences) was used with the following program at 20 °C in
the dark: constant current of 1 mA; constant power of 5
W; 500 V for 0.01 h; 500 V for 3 h; gradual ramping from
500 to 3,500 V over 5 h; and 3,500 V for 12.5 h. Unless
used immediately for second dimension electrophoresis,
IEF gels were wrapped in plastic, placed in airtight tubes,
flash frozen in liquid nitrogen, and stored at -80 °C until
use.
SDS-polyacrylamide gel electrophoresis
The second dimension gels were 1 mm thick, 4-20 %
SDS-polyacrylamide gels cast in low-fluorescence glass
plates (Jule Biotechnologies, Milford, CT, USA). Electro-
focused gels were incubated for 15 min in the dark in re-
ducing buffer (0.5 M Tris-HCl, pH 6.8, 10 mg
dithiothreitol/mL), followed by incubation for 15 min in
alkylation buffer (10 % reduction buffer without dithio-
threitol, 6 M urea, 30 % glycerol, 1 % SDS, 25 mg iodoa-
cetamide/mL), placed on the SDS gel, and sealed with 1
% low-melt agarose. Fluorescent Mr standards (Sigma)
were used. Electrophoresis was run at 25 °C (2 W/gel,
45 min; 17 W/gel, 3-4 h). Gels were stored moist in the
dark at 4 °C overnight.
CyDye-protein fluorescence was imaged on a Molecu-
lar Dynamics Typhoon 9410 Variable Mode Imager at a
resolution of 100 pixels/μm. The gel that would be used
for picking protein spots (“pick gel”) was then stained
with SimplySafe Coomassie blue (Invitrogen), and fixed
using two to three cycles of a 15 min wash in 10 % etha-
nol, followed by a 15 min wash in water. The Coomassie
staining of the pick gel was then imaged.
Protein spot comparison: DeCyder™ analysis
Gel images were analyzed using DeCyder™ (GE) to de-
tect protein spots in each gel. Spots were excluded if
they had slopes >1.3, areas <260 pixels, volumes <45,000
pixels, and peak heights <600 or >65,000 relative fluores-
cence units. Spots resulting from the Mr standards were
also excluded to prevent them from being used in the
statistical analysis of biological variance. The rest of the
spots were analyzed manually to ensure accurate dis-
crimination. The software then used the Cy2 standard,
included in each gel, to match each protein spot to its
related spots in the other gels. This matching was again
checked manually and corrected, as needed. Finally, a
“pick list” was generated by comparing all occurrences
of each spot between gels and choosing those spots
whose average volumes were > ±1.5-fold different from
the standard (p ≤ 0.05).
Mass spectrometric identification of protein spots
Protein spots from the “pick list” were cut out of the gel
in 1 mm2 pieces, destained, and digested overnight at 37
°C in trypsin (0.02 μg/μL in 25 mM Tris-HCl, pH 8.0)
(Promega, Madison, WI, USA) to just cover the gel
pieces, with extra buffer on top. Peptides were extracted
with 60 % acetonitrile/3 % trifluoroacetic acid and dried.
Mass spectrometry analysis of gel digest samples was
generously performed by Dr. Lewis Pannell (University of
Alabama). Samples, dissolved in 15 μL 1 % acetic acid/2 %
acetonitrile, were run on an ESI-TRAP mass spectrometer
(ThermoElectron LTQ Orbitrap) coupled to an Agilent
1200 nano LC system with a C18 reverse phase column,
eluted with 5-90 % acetonitrile (in 0.2 % formic acid) over
40 min. The acquired data files were converted into Mas-
cot generic format (.mgf) and matched against the Swiss
Protein (Sprot) Homo sapiens database through the MAS-
COT search engine (http://www.matrixscience.com). The
following additional parameters were used: fixed iodoace-
tamidation of cysteines, variable deamidation, standard
scoring, and requiring at least one unique peptide per pro-
tein match (“require bold red”). Mass accuracy for precur-
sor ions was set to ±10 ppm and ±0.6 Da for MS/MS
fragmentation data. Only proteins with at least three sig-
nificant peptide matches (p < 0.05) and ion scores ≥200
were considered. Proteins that were identified in gel
blanks or that matched the proteins of the Mr markers
were excluded from further analysis.
Ingenuity analysis
In silico analysis and compilation of gene expression
profiles and 2D-DIGE protein data was performed using
Ingenuity Systems software (Qiagen). Changes ≥3-fold of
normalized gene expression from MSCs in OM on matrix
versus plastic were analyzed with their corresponding p-
values (≤0.1). For each gene, the fold change at day 6 or
day 12 that had the higher value and/or the greater signifi-
cance was chosen to represent that gene. Proteins identi-
fied by mass spectrometry in the 2D gels were analyzed
together with their maximum scores from Mascot.
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Statistical analysis
All statistical comparisons used an unpaired Student’s
t-test with a p-value of ≤0.05, unless otherwise specified.
Graphic portrayals of the data show either standard devia-
tions (SD) or standard errors of the mean (SEM), as speci-
fied. Data analysis was performed using Prism (GraphPad
Software, La Jolla, CA, USA), Excel (Microsoft, Redmond,
WA, USA), FlowJo (Tree Star, Ashland, OR, USA), and
ImageQuant (GE).
Results
MSC/OBC direct contact cultures
To assess the osteogenic progression of MSCs cultured in
direct contact with OBCs, RT-PCR and human osteogenesis
Superarray analyses were performed on FACS-sorted
MSCs that had been labeled with DiI and then co-
cultured with OBCs while undergoing osteogenic differen-
tiation. We first verified that the DiI labeling did not alter
MSC gene expression or morphology (Additional file 2:
Figure S1). Our results showed that in mixed co-cultures,
no obvious morphological differences (Additional file 3:
Figure S2) nor consistent changes in gene expression
(Additional file 4: Figure S3) were seen (n = 5).
MSC Osteogenesis in OBC-Conditioned medium
To further characterize the nature of OBC-to-MSC sig-
naling, MSCs were cultured in OM that had previously
been conditioned by OBCs during days 11-14 of their
Fig. 1 Lysis of osteoblastic cells. MSC cultures were osteogenically differentiated for 15 days, lysed with DOC or water, and examined
microscopically. a-c Phase contrast images of residual matrix after lysis. d-f Fluorescent live (green)/dead (red) merged images. g-i AlzR staining of
matrix calcification. j-l blue staining of ALP enzymatic activity. (a, d, g, j) OBCs before lysis. (b, e, h, k) OBCs after DOC lysis. (c, f, i, l) OBCs after
water lysis. Microscopy images taken at 10×. MSC mesenchymal stem cells, AlzR Alizarin Red S, ALP alkaline phosphatase, OBCs osteoblastic cells
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osteogenic progression. MSC expression of OC, ALP,
Col I and Runx2, as assayed by real time RT-PCR, was
not significantly different in OBC-conditioned OM versus
the AOM control (Additional file 5: Figure S4). None of
the changes in gene expression were greater than 1.7-fold
and none of them were statistically significant (n = 3). This
was confirmed by AlzR histological staining of matrix
mineralization and ALP histochemical staining (data not
shown).
Mineralization of MSCs on OBC Matrix
Nascent osteoblastic ECM was prepared by lysing OBCs
with water or with 0.5 % DOC, producing matrices of
distinct complexities. Water lysis was chosen because it
does not denature proteins and therefore leaves the
ECM mostly intact; DOC was used to decrease the com-
plexity of the ECM by extracting some membrane pro-
teins while being sufficiently mild to leave behind most
of the ECM. While these treatments left behind predict-
ably different amounts of matrix proteins and cellular
debris (Fig. 1a-c), both lysis methods efficiently killed all
OBCs (Fig. 1d-f ). AlzR and ALP staining was generally
depleted by both lysis methods (Fig. 1g-l), although more
ALP activity was retained after water lysis (Fig. 1l).
To assess the effects of OBC matrix on MSC osteo-
genesis, MSCs were seeded on top of both types of
matrix. MSCs on water-treated (but not DOC-treated)
matrix increased their mineralization compared to those
seeded on plastic, as shown by AlzR staining (Fig. 2a-c).
While water-treated OBC matrix could mineralize
heavily in OM without live MSCs on top (Fig. 2f ), pos-
sibly due to the presence of matrix calcium binding pro-
teins, such as osteocalcin, the mineralization seen with
MSCs present was substantially more intense (Fig. 2c).
This increase was not due to an increase in MSC prolif-
eration on matrix. In fact, calcein fluorescence staining
showed that MSCs proliferated slightly less on water-
treated OBC matrix than on plastic, and they prolifer-
ated very little when plated on DOC-treated matrix
(Fig. 3a). As expected, MSC proliferation was lower in
OM than in EM, but, interestingly, this decrease was not
apparent when MSCs were plated on water-treated
matrix (Fig. 3b).
Gene expression and morphology of MSCs on
decellularized OBC matrix
Although our initial observations based on increased
AlzR staining suggested that OBC matrix could enhance
MSC osteogenesis, gene expression analysis suggested
otherwise. Real time RT-PCR analysis of three key osteo-
blastic genes, Runx2, ALP, and Col I, consistently
showed down-regulation in MSCs seeded on OBC
matrix versus plastic (n = 5) (Fig. 4). Only OC expression
showed no significant differences between plastic and
DOC- or water-treated matrix cultures (Fig. 4a). Runx2
levels dropped by nearly 50 % on both matrices at day 6
of culture. While these large decreases were not main-
tained through day 12, the downward trend remained.
ALP levels were only one-third as high on both matrices
as on plastic at day 6. Day 12 ALP levels on DOC matrix
Fig. 2 Water-treated OBC matrix enhances matrix mineralization of MSCs. OBC matrix was prepared from the cells shown in Fig. 1 at day 15 of
osteogenic induction. Cultures were stained with AlzR to detect mineralization. MSCs are shown on plastic at day 12 of culture in EM (d) and OM
(a). e DOC- and (f) water-treated matrices, without MSCs on top and maintained in OM for 12 days, show that water-treated OBC matrix sometimes
remineralizes on its own (f). b and c show MSCs seeded on DOC- and water-treated OBC matrix, respectively, after 12 days in OM. DOC-matrix did not
affect mineralization compared to cells on plastic (a). While water-treated matrix alone (f) showed a high level of AlzR staining even in the absence of
live cells, the presence of MSCs enhanced staining (c). OBC osteoblastic cells, MSC mesenchymal stem cells, AlzR Alizarin Red S, EM expansion medium,
OM osteogenic medium
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were similar to those on plastic but levels on water
matrix remained at less than 50 % of those on plastic. Fi-
nally, Col I levels at day 6 dropped by 50 % on DOC
matrix and by 70 % on water matrix. At day 12, Col I
levels on DOC matrix were similar to those on plastic,
while those on water matrix were again only one-third
as high as those on plastic (p = 0.1). It is noteworthy that
for several genes, there was a trend suggesting that water
matrix suppressed osteogenic gene expression to a
greater extent than DOC matrix: Col I at day 6; OC,
ALP and Col I at day 12 (p < 0.1) (Fig. 4).
To confirm these data and broaden the number of genes
being assessed, we carried out real-time RT-PCR micro-
array analysis using human osteogenesis Superarrays
(see Additional file 6: Figure S5.pdf ). Changes ≥3-fold
were analyzed. The trends seen previously in the four
osteogenic markers (above) were somewhat altered,
presumably due to donor variability. Changes in ALP
and Runx2 levels did not reach three-fold, although
ALP levels were reduced by more than two-fold on
water-matrix on days 6 and 12 and on DOC-matrix on
day 6. Runx2 levels decreased by 2.3-fold on DOC-
matrix on day 6 but all other conditions elicited little
change. Twenty-one genes related to osteogenesis dis-
played ≥3-fold changes in MSCs on matrix, including
OC and Col I. All of them were down-regulated except
CSF2, CSF3, ITGA2, OC and VEGFA. OC was up only on
day 6 in MSCs on DOC-matrix. The down-regulated
genes included BGN, BMP4, CD36, CDH11, COL1A1,
COL1A2, COL4A3, COL10A1, COL11A1, COL12A1,
COMP, FGFR2, ICAM1, IGF1, IGF2, and MMP8. Overall,
while the Superarray data did not reflect the greater po-
tency of water-treated matrix versus DOC-treated matrix,
suppression of MSC osteogenesis by OBC matrix was
confirmed.
In support of this observed reduction in osteogenic
gene expression, we also noted that the MSCs cultured
on OBC matrix did not assume an osteoblastic morph-
ology. On plastic, MSCs showed a marked transform-
ation in shape from long and fibroblastic in EM (Fig. 5a)
to bunched and cuboidal in OM (Fig. 5b). However,
when these same cells were cultured in OM on either
DOC- or water-treated OBC matrix, their morphology
remained fibroblastic even through day 12 (Fig. 5c and d,
respectively).
Specificity of the effect of OBC-derived matrix
Finally, it should be noted that the observed effects of
OBC matrix on MSC osteogenesis appeared to be OBC-
specific. This was confirmed by comparing the effect of
OBC matrix on MSC osteogenesis to that of matrix de-
rived from human foreskin fibroblasts (HFF), prepared
using an identical water lysis decellularization protocol.
As shown in Additional file 7: Figure S6, HFF-derived
matrix did not suppress the ALP level as effectively as
OBC-derived matrix.
OBC matrix protein identification by 2D-DIGE
To begin identifying the proteins responsible for the ob-
served effects on MSC osteogenic differentiation, pro-
teins found in DOC and water matrix were compared
through 2D-DIGE (Fig. 6). The amount of each protein
from three samples of each matrix type was compared
Fig. 3 OBC matrix slows MSC proliferation in EM and OM. MSCs
were plated on plastic or DOC-treated or water-treated OBC matrix
and maintained in OM or EM. Their proliferation was examined on
culture days 6 and 12. a In OM, MSC proliferation was reduced by
2-fold on DOC-treated OBC matrix and 1.2-fold on water-treated
matrix. b MSC proliferation on plastic was 1.3-fold lower in OM than
in EM, but this reduced proliferation is absent when comparing cells
in EM and OM on water-treated OBC matrix. Fold changes are
compared to the pre-culture value and expressed as mean ± SEM.
Data are from a single experiment, representative of three experiments.
*, p < 0.5, **, p < 0.01, ***, p < 0.001. OBC osteoblastic cells, MSC
mesenchymal stem cells, EM expansion medium, OM osteogenic
medium, SEM standard error of the mean
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to the protein standard contained within each gel. Their
relative amounts were plotted on graphs (Fig. 7) and
compared. Table 1 shows the “pick list”, the 29 gel spots
found by DeCyder to be at least 1.5-fold more abundant
in one matrix versus the other (p < 0.05). Table 2 lists
the proteins identified by mass spectrometry from the gel
spots on the “pick list.” The most likely candidate pro-
teins, due to their known extracellular location, are those
of the ECM, including collagen type VI α1 and α3
(COL6A1, COL6A3), elastin microfibril interfacer (EMI-
LIN1), EGF-containing fibulin-like extracellular matrix
protein (EFEMP2), heat shock-induced serine protease
HTRA1, and TGF-β-induced protein (TGFBI). Several
plasma membrane proteins are also strong candidates,
including annexins A1, A2 and A6 (ANXA1, ANXA2,
ANXA6), flotillin (FLOT1), and fibronectin I (FN1).
COL6A1 and A3, EMILIN1, and FN1 were identified in
spots that were more intense in DOC-treated matrix,
while the others plus COL6A3 were more abundant in
water-treated matrix. (COL6A3 was present in more than
one protein spot.) These 11 proteins were organized by
Ingenuity into functional groups. Groups for cell morph-
ology, cellular assembly and organization, cellular growth
and proliferation, cell-to-cell signaling and interaction,
and cellular movement each included at least five of the
focus proteins and received p-values of <0.05. Their puta-
tive relationships with each other, and with the osteo-
blastic genes RUNX2, OC (BGLAP), COL1A2, and
Fig. 4 OBC matrix suppresses MSC expression of osteogenic genes. MSCs were seeded on top of OBC matrix (treated with water or DOC) and
cultured in OM for 6 and 12 days. Gene expression of a OC, Runx2, b ALP, and ColI was assayed by real-time RT-PCR. Expression levels were normalized
to GAPDH and shown as a percentage of the maximum level within each experiment. Values are means ± SEM of five experiments. Asterisks indicate
significance between experimental conditions and the OM control. Bars show significance between matrix conditions. #, p < 0.1, *, p < 0.05, **, p < 0.01,
***, p < 0.001. OBC osteoblastic cells, MSC mesenchymal stem cells, OM osteogenic medium, RT-PCR reverse transcription-polymerase chain reaction,
SEM standard error of the mean
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ALP(L), are shown in Fig. 8 (also see Additional file 8:
Table S2) . As few additional proteins as possible were
added (by Ingenuity) to allow each protein of interest to
have at least one connection to the network.
Discussion
In this study, we have attempted to model the bone mar-
row niche of adult MSCs in vitro by generating a nas-
cent osteoblast environment and testing its effect on
MSC osteogenesis. When RT-PCR was used after FACS
separation of cocultured MSCs, no differences were de-
tected in osteogenic transcript levels between MSCs cul-
tured with and without contact with OBCs. These
results are corroborated by the findings of Wang et al.
[15] in a similar study using mouse cells. These authors
mixed MC3T3-E1 mouse osteoprogenitor cells with
MSCs from GFP-transgenic mice, cultured them in OM
at a plating density of 5,000/cm2 for 21 days, then FACS
sorted the MSCs based on green fluorescent protein
(GFP) fluorescence, and analyzed the transcript levels of
osteogenic genes. Their results showed that direct cell-
cell contact with the osteoblastic cells did not signifi-
cantly alter the osteogenic differentiation of the MSCs.
As in our study, Wang et al. [15] also examined the ef-
fects of OB-secreted proteins on the osteogenesis of
MSCs. When mouse MSCs were cultured indirectly with
MC3T3 cells in OM using Transwell inserts, the prolif-
eration of neither cell type was affected, but matrix
calcification was enhanced and several osteogenic gene
transcript levels were significantly increased. The differ-
ences in our results may be related to the developmental
stage of the OBs used: the mouse MC3T3 osteogenic cell
line is derived from newborn mouse calvaria, while the
OBCs used here are recently derived from adult human
MSCs. It is also known that mouse and human MSCs do
not respond equivalently to all osteogenic stimuli [23].
Additionally, other studies have also reported a lack of
osteo-induction by OB-secreted factors. For example,
Gerstenfeld et al. [11] found that C3H10T1/2 mouse em-
bryonic MSCs did not increase their expression of OC
when co-cultured in Transwells with chick embryonic
calvarial OBs.
A number of studies have assessed the effects of vari-
ous ECMs and their individual components on the
osteogenic differentiation of mesenchymal cells [24, 25].
Although the experimental systems were usually simpli-
fied to examine the effects of a single ECM protein on
MSC osteogenesis, many of the studies reported conflict-
ing results. Shi et al. [21] found that Col I-coated plates
stimulated Col I, ALP and osteopontin gene expression
in rat neonatal calvarial cells (ROB-C26) without osteo-
inductive medium, but the Col I matrix was not suffi-
cient to induce ALP activity or the expression of TGF-
α1, TGF-β2 or BMP-6. Salasznyk et al. [26] concluded
similarly that human MSCs can be induced to differenti-
ate into OBs through contact with Col I or vitronectin,
Fig. 5 OBC matrix preserves the naïve, fibroblastic morphology of MSCs. Fluorescence microscopy of Calcein AM-labeled cells shows that, even at
day 12, MSCs cultured in OM and seeded on OBC matrices (c, DOC- and d, water-treated) retain their fibroblastic morphology, like MSCs cultured
in EM on plastic (a), instead of becoming cuboidal, like cells cultured in OM on plastic (b). a, b Viewed at day 6. OBC osteoblastic cells, MSC mesenchymal
stem cells, OM osteogenic medium, EM expansion medium
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without osteogenic supplements, as assessed via
mineralization and Col I, OPN and ALP mRNA. Cool
and Nurcombe [27], however, saw no differences in prolif-
eration, ALP activity or Runx2, Col I or OC mRNA levels
in murine MSCs seeded on Col I, FN1 or laminin sub-
strates and cultured in OM. (Note: culturing in EM was
not tested.) Nor did Heckmann et al. [28] observe an in-
duction of OC or Col I expression when human MSCs
were cultured on a three-dimensional Col I matrix. There
is thus no obvious consensus in the literature regarding the
effects of any single ECM protein on MSC osteogenesis.
While these apparent conflicts may be related to dif-
ferences of species, substrates or culture media, these
studies by their very nature are overly reductionistic in
terms of mimicking the in vivo environment since the
ECM is a complex mixture of multiple components, de-
posited in temporospatially specific configurations and
proportions that are important for their biological activ-
ities. To better approximate the in vivo niche, we chose
to examine the activity of the matrix laid down by nas-
cent osteoblastic cells. The native configuration of the
OBC ECM is preserved by keeping it on the original cul-
ture dishes, without decalcification, fixation, or extrac-
tion. In this context, it is instructive to review the classic
work of Urist on demineralized bone matrix (DBM) [20].
In Urist’s studies, adult human and rabbit bones were ly-
ophilized and decalcified and implanted into various
muscles and bone defects. The DBM induced new bone
Fig. 6 2D-DIGE analysis of OBC matrix proteins. a A fluorescent image of a representative 2D gel. Blue bands at left represent fluorescent Mr
standards. DOC-treated OBC matrix proteins were labeled with Cy3 (green); water-lysed OBC matrix proteins with Cy5 (red). The linear, immobilized IEF
gradient gel is at the top with the acidic end (pH 3) at the left and the basic end (pH 10) at the right. The white box shows the approximate area of the
Coomassie-stained gel shown in (b) from which the protein spots were excised. Excised spots are circled in pink and labeled with a spot number.
2D-DIGE 2D-differential in-gel electrophoresis, OBC osteoblastic cells, IEF isoelectric focusing gel
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formation within the rings of decalcified matrix. How-
ever, a later study showed that the principal inducers re-
sponsible for DBM-induced osteogenesis were BMPs
sequestered in the bone matrix [29]. This was further
verified by Becerra et al. [30] who found that DBM could
also enhance MSC osteogenesis indirectly through
Transwell inserts. The fundamental difference between
DBM and the ECM used here is one of age and struc-
ture. As bone matures over time, growth factors, such as
BMPs, are sequestered within the bone matrix, particu-
larly in the mature trabecular and cortical bone, as new
layers of ECM are deposited and mineralized. The new
matrix used here, synthesized by nascent OBCs and
grown on a two-dimensional surface, is less likely to en-
trap growth factors. It more closely mimics that laid
down by bone-lining cells at the endosteal surface of the
bone marrow cavity, i.e., it is similar to the osteoblastic
matrix that MSCs likely encounter in vivo. Enhancement
of MSC osteogenesis seen with mature bone matrix
likely mimics what MSCs experience during fracture
healing when trabecular or cortical bone is exposed
along with its matrix and bound growth factors [31, 32].
MSCs, recruited to the site, thus come into contact with
the growth factor-laden mature bone, which then in-
duces them to begin osteogenic differentiation to repair
the fracture.
One other study elegantly demonstrates the import-
ance of the maturity of the OB matrix being studied
[33]. ECM was produced by neonatal rat calvarial cells
(ROB-C26) cultured with or without retinoic acid, which
induces osteogenesis in these cells. ECM made by the
more osteoblastic cells was able to induce osteogenesis
in naïve C26 cells in vitro and in vivo. However, ECM
synthesized by C26 cells in the absence of retinoic acid
was only able to partially stimulate osteogenesis in vitro
and not at all in vivo.
Furthermore, Chen et al. [34] showed that ECM from
murine MSCs themselves enhanced MSC proliferation
and slowed their spontaneous osteogenic differentiation,
while enhancing their tri-lineage plasticity. A second
study confirms this in human MSCs and identifies sev-
eral of the proteins present in the ECM (Col I, Col II,
FN, byglycan, decorin, perlecan, and laminin) [35].
The fact that MSCs’ own matrix can help maintain
their stemness [35] is particularly interesting, not only
because of its implications for the MSC niche, but also
because it suggests that “concentrations” of ECM are
important. Because MSC ECM is always available to
MSCs, if this contact were sufficient to maintain their
stemness, they would have to halt production of ECM
proteins and withdraw from their ECM before differenti-
ating. While this could be one explanation, there could
also be thresholds of MSC-ECM interactions that must
be reached before certain effects occur. Indeed, a similar
idea was proposed by Volloch and Olsen [36] regarding
the effect that the “density” of integrin-binding sites
within various matrices has on MSC differentiation.
In addition to these quantitative thresholds of interact-
ing ECM, apparently achieved in the OBC matrix stud-
ied here, there are likely qualitative characteristics of the
OBC matrix, i.e., specific components that are important
for the control of the differentiation activities of MSCs.
Therefore, we compared the protein compositions of the
DOC- and water-lysed OBC matrices using 2D-DIGE.
Eleven focus proteins were chosen because of their
characterization as ECM or membrane proteins, which
makes them most likely to be in contact with MSCs in
vivo. These were FN1, COL6A1, COL6A3, ANXA1,
ANXA2, ANXA6, HTRA1, flotillin (FLOT1), EMILIN1,
EFEMP2, and TGFBI. Several of these proteins have
already been implicated in stem cell functions or
osteogenesis. FN1, for example, was found in the
Fig. 7 Graphs showing the relative abundance of matrix proteins from different spots. a Spot 449. b Spot 1096
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MSC ECM reported in the study mentioned above to
suppress MSC osteogenesis [34]. It has also been
used to coat tissue culture dishes to enhance the pro-
liferation and plasticity of a subpopulation of MSCs
[5, 37]. ANXA1 and 2 are up-regulated in amputated
tadpole tails undergoing regeneration [38]. Interest-
ingly, they were also both identified in a proteomic
analysis of mouse embryonic fibroblasts, which are
the feeder layers cells used to maintain embryonic
stem cells in vitro [39].
TGFBI binds collagen types I, II and IV and is
expressed in most tissues [40]. It has been shown to be
highly expressed in HSCs that adhere well to MSCs [41].
This observation is significant because the binding of
HSCs to MSCs has been implicated in the maintenance
of the HSC phenotype in culture [42]. In addition, when
TGFBI is exogenously added to periodontal ligament
cells, it can inhibit their mineralization, suggesting an
anti-osteogenic function [43]. Recent research shows
that HTRA1 may play a similar role since it inhibited
mineral deposition in immortalized murine OBs (2 T3
cells) even in the presence of BMP-2 [44]. The same
study also showed that its overexpression reduced levels
of Runx2 and Col I mRNA. However, further research,
using human MSCs, showed an opposite effect for
HTRA1 [45], although it did confirm that HTRA1
Table 1 “Pick List” of statistically significant protein spots for identification
Spot No. Avg. ratio p-value (t-test) Spot Vol. pI Mr Match quality
201 5.32 0.019 N/A 5.65 133,581 1.80
203 5.69 0.015 1,809,098 5.72 133,294 2.38
208 6.21 0.015 1,387,720 5.81 132,723 1.78
210 7.48 0.015 2,038,969 5.90 131,588 0.74
214 7.7 0.015 2,700,438 6.00 130,462 0.52
216 7.72 0.015 2,774,451 6.09 129,903 0.47
224 5.93 0.015 11,334,140 4.82 127,965 2.77
242 6.59 0.019 1,651,536 5.24 121,536 3.41
247 4.71 0.015 2,109,428 5.39 120,497 5.05
449 7.28 0.019 1,501,211 4.76 82,040 1.30
486 −1.6 0.038 1,347,174 4.59 75,936 2.60
562 −3.64 0.026 1,435,516 6.56 66,327 2.55
565 −3.31 0.030 2,230,394 6.85 66,184 1.05
566 −1.73 0.043 258,223 7.15 66,184 2.82
607 −2.65 0.015 1,380,551 5.02 61,260 3.09
637 −2.67 0.036 4,584,544 4.16 57,933 0.77
649 −4.96 0.015 746,894 6.09 57,561 12.13
658 −1.52 0.031 773,745 6.43 56,824 3.03
689 −1.73 0.049 3,281,833 4.82 54,319 0.67
717 −2.11 0.041 5,864,175 4.42 51,923 0.70
758 −2.09 0.041 750,800 7.99 48,788 3.34
826 −2.69 0.034 2,653,198 5.71 42,890 2.37
894 −1.93 0.015 1,912,332 5.17 38,606 5.09
895 −1.83 0.041 694,589 4.97 38,275 2.33
896 −3.09 0.015 5,361,677 5.35 38,440 2.96
1053 −2.63 0.036 2,984,453 4.99 27,203 1.65
1093 −7.66 0.015 6,128,338 7.30 24,017 2.46
1095 −4.59 0.023 1,765,854 6.92 23,914 1.91
1096 −7.55 0.015 13,937,178 7.60 23,812 0.52
DeCyder-generated list of proteins whose abundances vary by at least ±1.5-fold (p ≤ 0.05) between DOC- and water-treated OBC matrices. Columns show (left to
right): numbers assigned to each spot on the gel; average ratios between spot volumes (DOC/water); p-values corresponding to those ratios; maximum spot
volumes (pixels); approximate pIs and Mr (Daltons) based on position within the gel; and match quality, a measure of consistency between a spot’s replicates in
different gels (lower is better). Spots above the double line are more abundant in DOC matrix, below, in water matrix
OBC osteoblastic cell
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Table 2 Identities of Proteins from "Pick List"
Symbol Entrez Gene Name Found in Spots: Mx Max Score pI Mr
CYTOPLASM ACTA2 actin, alpha 2, smooth muscle, aorta 826, 894–6, 1053 W 348 5.23 42,381
ALDH1B1 aldehyde dehydrogenase 1 family, member B1 658 W 283 6.36 57,658
AKR1C1 aldo-keto reductase family 1, member C1 894 W 240 8.02 37,221
ATP5A1 ATP synthase, H+ transport, mitoch F1 complex, alpha 1 658 W 867 9.16 59,828
ATP5B ATP synthase, H+ transport, mitoch F1 complex,
beta
689 W 683 5.26 56,525
CKAP4 cytoskeleton-associated protein 4 717 W 821 5.63 66,097
ENO1 enolase 1, alpha 758, 759 W 532 7.01 47,481
ENO3 enolase 3, beta, muscle 758 W 246 7.59 47,299
EIF3B eukaryotic translation initiation factor 3, subunit B 896 W 213 5.38 36,878
FH fumarate hydratase 758, 759 W 290 8.85 54,773
HSP90B1 heat schock protein 90kDa beta (Grp94), member 1 449, 636, 637 B 306 4.76 92,696
HSPB1 heat shock 27kDa protein 1 1053 W 315 5.98 22,826
HSPD1 heat shock 60kDa protein 1 (chaperonin) 607 W 390 5.83 60,813
HSPA5 heat shock 70kDa protein 5 (glucose-regulated) 449, 486 B 1483 5.07 72,402
IKIP IKK interacting protein 717 W 487 9.21 39,399
PRDX1 peroxiredoxin 1 1093 W 363 8.27 22,324
P4HB prolyl 4-hydroxylase, beta polypeptide 201, 607, 636 B 1116 4.76 57,480
PSMD13 proteasome (prosome, macropain) 26S subunit, 13 826 W 219 5.71 42,872
PDIA3 protein disulfide isomerase family A, member 3 647-9 W 706 5.98 57,146
PDIA6 protein disulfide isomerase family A, member 6 689 W 395 5.35 48,207
PDHB pyruvate dehydrogenase (lipoamide) beta 896 W 202 6.20 39,550
PKM2 pyruvate kinase, muscle 607 W 341 7.96 58,470
SOD2 superoxide dismutase 2, mitochondrial 1093-6 W 347 8.35 24,878
TUBA1A tubulin, alpha 1A 689, 894 W 494 4.94 50,788
ECM COL6A1 collagen, type VI, alpha 1 201, 203, 208, 210, 224, 242, 247 D 1432 5.26 109,602
COL6A3 collagen, type VI, alpha 3 247, 607, 649 B 321 6.26 345,163
EFEMP2 EGF-containing fibulin-like ECM protein 2 636 W 297 4.79 51,725
EMILIN1 elastin microfibril interfacer 1 224-6, 242, 247 D 462 5.07 107,913
HTRA1 HtrA serine peptidase 1 637 W 267 8.09 52,167
TGFBI transforming growth factor, beta-induced, 68kDa 486 W 247 7.62 75,261
PM ANXA1 annexin A1 894-6 W 397 6.57 38,918
ANXA2 annexin A2 894-6 W 1201 8.44 36,950
ANXA6 annexin A6 486 W 265 5.42 76,168
FN1 fibronectin 1 all but 1093-96 D 2242 5.45 266,034
FLOT1 flotillin 1 758 W 496 7.08 47,554
NU CRYAB crystallin, alpha B 1093-6 W 244 6.76 20,146
LMNA lamin A/C 561-66 W 1179 6.57 74,380
Columns show (left to right): the number(s) of the spot(s) where a given protein was found; the type of matrix in which the protein was more abundant
(D = DOC, W = water, B = both); maximum Mascot identity score from mass spectrometry; and theoretical pIs and Mr values determined by Mascot from the
protein sequences. Bolded text indicates that the approximate pI and/or Mr of the spot in which the protein was found match its theoretical values. Proteins are
grouped by subcellular location based on Ingenuity’s database
NU nucleus, ECM extracellular matrix, PM plasma membrane
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secretion from MSCs increases as they undergo osteo-
genesis and, in mice, it is found mostly in areas of new
bone formation after fracture.
EMILIN1 has not yet been linked to bone tissues but is
known to bind pro-TGF-β, a key regulator of osteogenesis,
in the extracellular space of blood vessels [46]. This binding
inhibits the maturation of TGF-β, the purpose of which
may be the prevention of fibrosis due to Col I buildup [46].
To date, several studies have shown that ECMs gener-
ated by various cell types in vitro, including MSCs them-
selves, can encourage MSC stemness and suppress their
differentiation [34, 47–50]. It is unlikely that there is a
single MSC niche produced by a single cell type. Indeed
MSCs are found throughout the body in various tissues.
To discover which proteins are most important in main-
taining and expanding MSCs, one approach would be to
compare the proteins present in OBC ECM to those
found in other stemness-enhancing ECMs. Since the
ECM generated by MSCs of older mice has been shown
to be less efficient in maintaining their stemness [51], we
suggest that the protein makeup of ECMs from human
donors of various ages be compared as well.
Conclusions
In summary, our study has shown an osteo-inhibitory
function for OBC matrix laid down in vitro by nascent
osteoblasts derived from osteogenically differentiated
MSCs. The OBC matrix is likely to be similar to that laid
down by newly-formed, active OBs that line the endos-
teal surface in the bone marrow milieu. Since only MSC
osteogenesis is examined here, whether the “niche effect”
seen is specific to osteogenesis only or applicable to the
Fig. 8 Connections to regulators of osteogenesis and cellular proliferation exhibited by proteins identified by 2D-DIGE. This network, generated
by Ingenuity®, portrays relationships described in the literature between all of the proteins identified by 2D-DIGE. Runx2 was added to emphasize
the participation of these proteins in the osteogenic pathway. The proteins from the gel spots are colored in varying shades of red relative to the
match score they received from Mascot. Together with TGF-β1, Runx2 and TP53 are hubs for regulation of osteogenesis and cellular proliferation.
(Note: Gray arrows indicate action, not up/down-regulation. Only lines leading to and away from the four focus genes are color-coded.) Protein
symbols are listed in (Additional file 8: Table S2). 2D-DIGE 2D-differential in-gel electrophoresis
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maintenance of MSC stemness in general remains to be
investigated. In either case, it may be that MSCs in the
marrow stroma are often in contact with similar nascent
OB matrix and are thus kept in an undifferentiated state.
In a traumatic bone injury setting, MSCs would be
called forth to migrate from their niche to the site of
fracture where they would come into contact with ma-
ture bone and its matrix, which would then act to stimu-
late their osteogenic differentiation via matrix-entrapped
growth factors. This model, if proven correct, will
strongly suggest that the OBC matrix and/or its active
components may be applied in vitro to develop a means
to extend the proliferative potency and therapeutic util-
ity of MSCs by suppressing their default osteogenic
differentiation.
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Additional file 1: Table S1. Primer sequences of genes analyzed by
real-time RT-PCR for osteogenesis. (DOCX 50 kb)
Additional file 2: Figure S1. DiI labeling does not affect MSC
osteogenic gene expression. MSCs were labeled with DiI and cultured in
EM or OM for 21 days. Osteocalcin (OC) mRNA expression was measured
by real-time RT-PCR and normalized to GAPDH. Unlabeled MSCs were
used as controls. Values shown are mean ± SD from cells isolated from a
61-year-old male donor, plated at 3,000/cm2. (JPEG 305 kb)
Additional file 3: Figure S2. Morphology of DiI-labeled MSCs in
co-culture with unlabeled OBCs. Images of MSCs on culture days 6 and
12 show no obvious morphological differences due to co-culture with OBCs.
Shown are unlabeled MSCs in EM; DiI-labeled MSCs mixed with unlabeled
MSCs in OM as a control (MSC/MSC*); and DiI-labeled MSCs mixed with
unlabeled OBCs in OM (OBC/MSC*). MSCs were derived from a 73-year-old
male donor, plated at 9,000 cells/cm2 and cultured in a 1:4 ratio with OBCs
induced from the same MSCs for 15 days prior to co-culture. MSC* indicates
MSCs labeled with DiI (red). 10× magnification. (JPEG 1025 kb)
Additional file 4: Figure S3. Effects of OBC co-culture on MSC osteogenic
gene expression is variable. mRNA levels of osteogenic genes (OC,
Runx2, ALP, and Col I) in MSC control cultures and MSC/OBC co-cultures
were measured via real-time RT-PCR, and normalized to GAPDH. Each
value was then expressed as a percentage of the maximum level reached
for that gene in cells from a given donor within a given experiment. Values
shown are the mean ± SEM from two experiments. No statistically significant
differences were observed. (JPEG 238 kb)
Additional file 5: Figure S4. Minimal effects of OBC-conditioned
medium on MSC osteogenic gene expression. mRNA levels of OC, Runx2,
ALP, and Col I measured via real-time RT-PCR (normalized to GAPDH)
were compared between MSCs in OBC-conditioned OM (CM) versus
those in the control aged OM (AOM) cultured for 3, 6 and 12 days. Mean
fold changes on each day from three experiments are shown (mean ± SD).
None of the changes in gene expression upon exposure to OBC-
CM were greater than 1.7-fold, and none of them were statistically
significant. (JPEG 147 kb)
Additional file 6: Figure S5 Microarray analysis confirms the
suppression of osteogenesis by OBC matrices. MSCs from three donors
were cultured in OM on OBC matrices prepared by water or DOC lysis,
and gene expression analyzed by real-time RT-PCR using the SuperArray
System. Gene-of –interest CT values were normalized to the average of
five housekeeping genes. Shown are those genes that showed mean fold
changes > 3-fold when comparing MSCs on matrix to MSCs on plastic in
OM at days 6 and 12. Genes were assigned to graph (A) or (B) based on
alphabetical order. Asterisks indicate significance between an experimental
condition and the OM plastic control. There was no statistical significance in
any differences >3-fold between matrix treatments. *, p < 0.05; **, p < 0.01.
(JPEG 427 kb)
Additional file 7: Figure S6. Comparison of the matrix effect of human
foreskin fibroblasts and osteoblastic cells on osteogenic differentiation of
MSCs. HFF and OBC cultures were water-lysed and the resultant matrices
used as a substrate for MSCs cultures maintained in osteogenic medium.
ALP activity was detected histochemically. Non-MSC seeded HFF and
OBC matrices were used as control. The results showed that HFF matrix
did not suppress MSC osteogenesis, compared to OBC matrix. OBCs were
derived from day-15 osteogenic culture of bone marrow derived MSCs
from a 47-year-old female donor. (JPEG 637 kb)
Additional file 8: Table S2. Protein symbols used for proteomic
analysis. (DOCX 122 kb)
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